Mexico Secures COVID-19 Vaccine Candidates from CanSino Biologics & Others Via COVAX
Mexico was active recently in the investigational vaccine market, securing two deals with two different companies for a total of […]
Mexico was active recently in the investigational vaccine market, securing two deals with two different companies for a total of […]
Indonesia is preparing to support the commercialization of CanSino Biologics’ Ad5-nCoV vaccine candidate as Solution Biologics Sdn Bhd (SOLBIO), a […]
Canada has finally made the call to terminate the CanSino Biologics Ad5-nCoV clinical trial, the nation’s first such study targeting […]
Although TrialSite has already reported that the Canadian government has gone to a “Plan B” for COVID-19 vaccines, the issue […]
www.petrocax.com, a Russian pharmaceutical company has inked a deal with CanSino Biologics (CanSinoBIO) to drive Phase 3 clinical trials in Russia. The […]
The China National Biotec Group Co. (CNBG) announced its commencing Phase 3 clinical trials of its COVID-19 vaccines in both […]
The COVID-19 vaccine race moved full throttle into the Middle East and North Africa (MENA) region as trial sites in […]
Canada made the timely move to strike a deal with the Project Lightspeed sponsors Pfizer and BioNTech SE to diversity […]
The Canadian government is showing patience and tenacity sticking with Chinese vaccine partner CanSino Biologics, despite the fact that even […]
Nearly two months ago, TrialSite News announced Canada was ready to sign a deal with China’s CanSino Biologics to supply […]